Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy

Journal of Neuropathology and Experimental Neurology

Volumn 71, Issue 6, 2012, Pages 494-510

  Kan, Michelle ^a   Guo, Guifang ^a   Singh, Bhagat ^a   Singh, Vandana ^a   Zochodne, Douglas W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Diabetes mellitus; Diabetic neuropathy; Exendin 4; Glucagon like peptide 1; Insulin; Polyneuropathy

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DIABETIC NEUROPATHY; DISEASE DURATION; DOSE RESPONSE; DRUG MEGADOSE; ELECTROPHYSIOLOGY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LOW DRUG DOSE; MALE; MOTOR NERVE CONDUCTION; MOUSE; NERVE FIBER; NERVE FIBER GROWTH; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SENSORY NERVE CELL; SPINAL GANGLION; STREPTOZOCIN DIABETES;

ANIMALS; AXONS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; GLUCAGON-LIKE PEPTIDE 1; HEMOGLOBIN A, GLYCOSYLATED; IMMUNOHISTOCHEMISTRY; INSULIN; MALE; MICE; MOTOR NEURONS; NEURAL CONDUCTION; PEPTIDES; PERIPHERAL NERVES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCAGON; SENSORY RECEPTOR CELLS; SIGNAL TRANSDUCTION; VENOMS;

EID: 84861460226     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182580673     Document Type: Article

References (56)

1. Perry T, Lahiri DK, Chen D, et al. A novel neurotrophic property of glucagon-like peptide 1: A promoter of nerve growth factorYmediated differentiation in PC12 cells. J Pharmacol Exp Ther 2002;300:958-66 (Pubitemid 34165002)
2. Nakagawa A, Satake H, Nakabayashi H, et al. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton Neurosci 2004;110: 36-43 (Pubitemid 38180536)
3. During MJ, Cao L, Zuzga DS, et al. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med 2003;9:1173-79 (Pubitemid 37173702)
4. Perry T, Haughey NJ, Mattson MP, Egan JM, Greig NH. Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4. J Pharmacol Exp Ther 2002;302:881-88 (Pubitemid 34920207)
5. Perry T, Holloway HW, Weerasuriya A, et al. Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy. Exp Neurol 2007;203:293-301 (Pubitemid 46157226)
6. Liu WJ, Jin HY, Lee KA, Xie SH, Baek HS, Park TS. Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats. Br J Pharmacol 2011; 164:1410-20
7. Himeno T, Kamiya H, Naruse K, et al. Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice. Diabetes 2011;60: 2397-406
8. Jolivalt CG, Fineman M, Deacon CF, Carr RD, Calcutt NA. GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice. Diabetes Obes Metab 2011;13:990-1000
9. Deacon CF, Nauck MA, Toft-Nielsen M, Pridal L, Willms B, Holst JJ. Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes 1995;44:1126-31
10. Simonsen L, Holst JJ, Deacon CF. Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs. Diabetologia 2006;49:706-12 (Pubitemid 43357544)
11. Kennedy JM, Zochodne DW. The regenerative deficit of peripheral nerves in experimental diabetes: Its extent, timing and possible mechanisms. Brain 2000;123:2118-29
12. Lindsay RM. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J Neurosci 1988;8:2394-405
13. Christie KJ, Webber CA, Martinez JA, Singh B, Zochodne DW. PTEN inhibition to facilitate intrinsic regenerative outgrowth of adult peripheral axons. J Neurosci 2010;30:9306-15
14. Toth C, Rong LL, Yang C, et al. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Diabetes 2008; 57:1002-17
15. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77-88
16. Cheng C, Guo GF, Martinez JA, Singh V, Zochodne DW. Dynamic plasticity of axons within a cutaneous milieu. J Neurosci 2010;30: 14735-44
17. Guo G, Kan M, Martinez JA, Zochodne DW. Local insulin and the rapid regrowth of diabetic epidermal axons. Neurobiol Dis 2011;43: 414-21
18. Lauria G, Cornblath DR, Johansson O, et al. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol 2005;12:747-58 (Pubitemid 41495131)
19. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007;132:2131-57 (Pubitemid 46711096)
20. Harkavyi A, Whitton PS. Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection. Br J Pharmacol 2010;159:495-501
21. Jones DM, Tucker BA, Rahimtula M, Mearow KM. The synergistic effects of NGF and IGF-1 on neurite growth in adult sensory neurons: Convergence on the PI3-kinase signaling pathway. J Neurochem 2003;86: 1116-28 (Pubitemid 37022188)
22. Francis G, Martinez J, Liu W, et al. Intranasal insulin ameliorates experimental diabetic neuropathy. Diabetes 2009;58:934-45
23. Pabbidi RM, Yu SQ, Peng S, Khardori R, Pauza ME, Premkumar LS. Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity. Mol Pain 2008;4:9
24. Calcutt NA, Jorge MC, Yaksh TL, Chaplan SR. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: Effects of insulin, aldose reductase inhibition and lidocaine. Pain 1996;68:293-99 (Pubitemid 27025887)
25. Cheng HT, Dauch JR, Hayes JM, Hong Y, Feldman EL. Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes. J Neuropathol Exp Neurol 2009;68:1229-43
26. Vareniuk I, Pavlov IA, Obrosova IG. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes. Diabetologia 2008;51:2126-33
27. Vareniuk I, Pavlov IA, Drel VR, et al. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice. Exp Neurol 2007;205:425-36 (Pubitemid 46755764)
28. Latham JR, Pathirathna S, Jagodic MM, et al. Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice. Diabetes 2009;58:2656-65
29. Obrosova IG, Li F, Abatan OI, et al. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 2004;53: 711-20 (Pubitemid 38270641)
30. Zochodne DW. Nerve and ganglion blood flow in diabetes: An appraisal. In: Tomlinson D, ed. Neurobiology of Diabetic Neuropathy. San Diego, CA: Academic Press, 2002:161-202
31. Beiswenger KK, Calcutt NA, Mizisin AP. Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice. Neurosci Lett 2008;442:267-72
32. Kennedy JM, Zochodne DW. Experimental diabetic neuropathy and spontaneous recovery: Is there irreparable damage? Diabetes 2005;54: 830-37 (Pubitemid 40322088)
33. Toth C, Brussee V, Zochodne DW. Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia 2006;49: 1081-88
34. Obrosova IG, Xu W, Lyzogubov VV, et al. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy. Free Radic Biol Med 2008;44: 972-81 (Pubitemid 351318144)
35. Kellogg AP, Wiggin TD, Larkin DD, Hayes JM, Stevens MJ, Pop-Busui R. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes 2007;56:2997-3005 (Pubitemid 350223635)
36. Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 1996;47:1042-48
37. Polydefkis M, Hauer P, Griffin JW, McArthur JC. Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol Ther 2001;3:23-28 (Pubitemid 32405674)
38. Jin HY, Liu WJ, Park JH, Baek HS, Park TS. Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats. Arch Med Res 2009;40:536-44
39. Singh B, Xu Y, McLaughlin T, et al. Resistance to trophic neurite outgrowth of sensory neurons exposed to insulin. J Neurochem 2012;121: 263-76
40. Fernyhough P, Mill JF, Roberts JL, Ishii DN. Stabilization of tubulin mRNAs by insulin and insulin-like growth factor I during neurite formation. Brain Res Mol Brain Res 1989;6:109-20 (Pubitemid 19270011)
41. Xu QG, Li X-Q, Kotecha SA, Cheng C, Sun HS, Zochodne DW. Insulin as an in vivo growth factor. Exp Neurol 2004;188:43-51 (Pubitemid 38748803)
42. Toth C, Brussee V, Martinez JA, McDonald D, Cunningham FA, Zochodne DW. Rescue and regeneration of injured peripheral nerve axons by intrathecal insulin. Neuroscience 2006;139:429-49
43. Sugimoto K, Murakawa Y, Zhang W, Xu G, Sima AA. Insulin receptor in rat peripheral nerve: Its localization and alternatively spliced isoforms. Diabetes Metab Res Rev 2000;16:354-63
44. Sugimoto K, Murakawa Y, Sima AA. Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord. J Peripher Nerv Syst 2002;7:44-53 (Pubitemid 34246037)
45. Brussee V, Cunningham FA, Zochodne DW. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 2004;53:1824-30 (Pubitemid 38857041)
46. Singhal A, Cheng C, Sun H, Zochodne DW. Near nerve local insulin prevents conduction slowing in experimental diabetes. Brain Res 1997; 763:209-14 (Pubitemid 27364440)
47. Hoybergs YM, Meert TF. The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy. Neurosci Lett 2007;417:149-54 (Pubitemid 46551356)
48. Huang TJ, Price SA, Chilton L, et al. Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 2003;52: 2129-36 (Pubitemid 36919808)
49. Sima AA, Lattimer SA, Yagihashi S, Greene DA. Axo-glial dysjunction: A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat. J Clin Invest 1986;77:474-84 (Pubitemid 16037646)
50. Dyck PJ, Giannini C. Pathologic alterations in the diabetic neuropathies of humans: A review. J Neuropathol Exp Neurol 1996;55:1181-93 (Pubitemid 26397137)
51. Greene DA, De Jesus PVJ, Winegrad AI. Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. J Clin Invest 1975;55:1326-36 (Pubitemid 8036495)
52. Biessels GJ, Stevens EJ, Mahmood SJ, Gispen WH, Tomlinson DR. Insulin partially reverses deficits in peripheral nerve blood flow and conduction in experimental diabetes. J Neurol Sci 1996;140:12-20 (Pubitemid 26273614)
53. Kennedy JM, Zochodne DW. The regenerative defict of peripheral nerves in experimental diabetes: Its extent, timing and possible mechanisms. Brain 2000;123:2118-29
54. Kamiya H, Zhang W, Sima AA. C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes. Ann Neurol 2004;56:827-35 (Pubitemid 39578446)
55. Ekberg K, Brismar T, Johansson BL, Jonsson B, Lindstrom P, Wahren J. Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes. Diabetes 2003;52:536-41 (Pubitemid 36210858)
56. Robertson DM, Sima AA. Diabetic neuropathy in the mutant mouse [C57BL/ks(db/db)]: A morphometric study. Diabetes 1980;29:60-67 (Pubitemid 10157190)